Clinical Trial: Feasibility Study for the SIRA-1000, SIRA(R) RFA Electrosurgical Device as an Adjunct to Breast Conserving Surgery.

U.S., Oct. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07206121) titled 'Feasibility Study for the SIRA-1000, SIRA(R) RFA Electrosurgical Device as an Adjunct to Breast Conserving Surgery.' on Sept. 18.

Brief Summary: This study aims to assess the safety and clinical accuracy of the SIRA-1000, SIRA(R) RFA Electrosurgical Device in ablating margins post-lumpectomy in patients undergoing breast conserving surgery for breast cancer. Radiofrequency ablation, or RFA, uses radio waves to create heat, that in turn, causes deliberate controlled damage to the tissue surrounding where the tumor was located. You may hear your doctor refer to this as the 'margins'. Your doctor is using this treatment to help destroy ...